CIK 0001178253
- Non-accelerated filer
- Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 562181648
- Phone
- +1 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- 4 Grant or award General Counsel acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 125,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 150,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $0.69 ($17,250)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $0.46 ($11,500)
- 4 Open-market buy Chief Medical Officer bought 12,000 shares at $0.50 ($5,951)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Medical Officer bought 7,000 shares at $1.27 ($8,890)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $1.29 ($32,250)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 16 · 314 filings